Trump’s administration this week abruptly terminated funding for a slew of studies designed to learn how to better treat the ...
A provision changed near the end of his first term is now facilitating hundreds of millions of dollars in cuts.
UMass Chan Medical School biomedical engineer and professor Rachael Sirianni leads a lab that researches new technologies to ...
INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results